Upgrades/Downgrades
Updated: 26-Jun-26 12:05 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Softbank | SFTBY | Deutsche Bank | Hold » Buy | ||
| Replimune | REPL | JP Morgan | Neutral » Overweight | $17 | |
| Tango Therapeutics | TNGX | Jefferies | Hold » Buy | $60 | |
| Qualcomm | QCOM | DZ Bank | Hold » Buy | $265 | |
| H.B. Fuller | FUL | JP Morgan | Neutral » Overweight | $67 | |
| FuelCell Energy | FCEL | Jefferies | Hold » Buy | $24 | |
| Diageo plc | DEO | TD Cowen | Hold » Buy | $93 | |
| Crocs | CROX | Piper Sandler | Neutral » Overweight | $150 | |
| Barnes & Noble Education | BNED | Needham | Hold » Buy | $16 | |
| American Tower | AMT | RBC Capital Mkts | Sector Perform » Outperform | $205 | |
| American Homes 4 Rent | AMH | BMO Capital Markets | Market Perform » Outperform | $39 | |
| Americold Realty Trust | COLD | Evercore ISI | In-line » Outperform | $18 | |
| Allegiant Travel | ALGT | Citigroup | Neutral » Buy | $156 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Visteon | VC | Robert W. Baird | Outperform » Neutral | $121 | |
| Trip.com Group | TCOM | Macquarie | Outperform » Neutral | $44.30 | |
| Spire | SR | JP Morgan | Overweight » Neutral | $85 | |
| onsemi | ON | TD Cowen | Buy » Hold | $110 | |
| NIKE | NKE | KeyBanc Capital Markets | Overweight » Sector Weight | ||
| Methode Electronics | MEI | Sidoti | Buy » Neutral | $17 | |
| Macerich | MAC | Compass Point | Buy » Neutral | $26 | |
| Braskem SA | BAK | Citigroup | Neutral » Sell | ||
| Quantum | QMCO | Northland Capital | Outperform » Market Perform | $13 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Robinhood Markets | HOOD | BTIG Research | Buy | $125 | |
| SpaceX | SPCX | Argus | Hold | ||
| VSE Corp | VSEC | Morgan Stanley | Equal-Weight | $245 | |
| Red Rock Resorts | RRR | Goldman | Buy | $72 | |
| Primis Financial | FRST | Raymond James | Strong Buy | $19 | |
| PENN Entertainment | PENN | Goldman | Buy | $26 | |
| Nu Holdings | NU | Needham | Buy | $17 | |
| Mosaic | MOS | Rothschild & Co Redburn | Buy | $30 | |
| James Hardie | JHX | Stephens | Overweight | $31 | |
| Infosys | INFY | Wells Fargo | Equal Weight | $11 | |
| Infleqtion | INFQ | Wedbush | Outperform | $20 | |
| Honeywell Aerospace | HONA | RBC Capital Mkts | Outperform | $300 | |
| Granite Constr | GVA | Stephens | Overweight | $180 | |
| First National | FXNC | Raymond James | Mkt Perform | ||
| Faeth Therapeutics | FTH | Robert W. Baird | Outperform | $57 | |
| Eupraxia Pharmaceuticals | EPRX | Oppenheimer | Outperform | $17 | |
| Dyne Therapeutics | DYN | TD Cowen | Buy | ||
| Connect Biopharma | CNTB | Piper Sandler | Overweight | $7 | |
| Boyd Gaming | BYD | Goldman | Neutral | $91 | |
| Belden | BDC | Citigroup | Buy | $150 | |
| NeoVolta | NEOV | Lake Street | Buy | $11 | |
| Nutex Health | NUTX | B. Riley Securities | Buy | $290 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Waters | WAT | Bernstein | Outperform | $435 | |
| Thermo Fisher | TMO | Bernstein | Mkt Perform | $520 | |
| SBA Comm | SBAC | Goldman | Neutral | $205 | |
| Revvity | RVTY | Bernstein | Mkt Perform | $115 | |
| Natera | NTRA | Bernstein | Outperform | $310 | |
| Illumina | ILMN | Bernstein | Mkt Perform | $185 | |
| Guardant Health | GH | Bernstein | Outperform | $175 | |
| Essex Property | ESS | Bernstein | Outperform | $320 | |
| Crown Castle | CCI | Goldman | Neutral | $95 | |
| Avantor | AVTR | Bernstein | Mkt Perform | $10.50 | |
| American Tower | AMT | Goldman | Buy | $215 | |
| Agilent | A | Bernstein | Outperform | $155 | |
| Achieve Life Sciences | ACHV | Raymond James | Strong Buy | $20 | |
| Provident Fincl | PROV | Piper Sandler | Neutral | $17 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |